CN Stock MarketDetailed Quotes
300497 Jiangxi Fushine Pharmaceutical
- 10.09
- -0.31-2.98%
Noon Break Dec 5 11:30 CST
5.55BMarket Cap-30575P/E (TTM)
10.23High9.83Low176.45KlotVolume10.23Open10.40Pre Close176.33MTurnover3.91%Turnover RatioLossP/E (Static)550.00MShares13.6852wk High2.32P/B4.56BFloat Cap5.6252wk Low12.48Limit Up451.62MShs Float29.40Historical High8.32Limit Down3.85%Amplitude2.55Historical Low--Dividend TTM9.99Avg Price81.34KlotAsk--Div YieldTTM100Lot Size88.96KlotBid
Jiangxi Fushine Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -24.06%976.88M | -20.25%682.41M | -14.45%340.43M | -2.28%1.61B | 4.40%1.29B | 2.95%855.65M | -1.10%397.92M | 15.23%1.65B | 15.59%1.23B | 7.13%831.15M |
| Operating revenue | -24.06%976.88M | -20.25%682.41M | -14.45%340.43M | -2.28%1.61B | 4.40%1.29B | 2.95%855.65M | -1.10%397.92M | 15.23%1.65B | 15.59%1.23B | 7.13%831.15M |
| Other operating revenue | ---- | -73.72%2.71M | ---- | -13.19%12.39M | ---- | 3.03%10.29M | ---- | -65.31%14.28M | ---- | -72.06%9.99M |
| Total operating cost | -21.03%1.08B | -19.63%735.16M | -19.35%347.98M | 9.24%1.77B | 14.28%1.36B | 15.84%914.72M | 15.75%431.47M | 28.38%1.62B | 32.09%1.19B | 28.98%789.64M |
| Operating cost | -22.92%880.03M | -20.87%611.47M | -18.89%288.91M | 6.55%1.44B | 14.27%1.14B | 16.50%772.72M | 17.29%356.2M | 35.89%1.35B | 37.61%999.14M | 32.00%663.3M |
| Operating tax surcharges | 10.26%12.63M | 28.27%8.57M | 44.28%4.78M | 9.33%16.66M | 1.99%11.45M | -17.47%6.68M | -19.08%3.32M | 4.47%15.23M | -4.07%11.23M | 3.55%8.1M |
| Operating expense | -56.66%12.65M | -59.73%7.9M | -73.79%2.36M | 3.30%35.34M | 14.77%29.18M | 43.73%19.61M | 16.37%8.99M | -0.83%34.21M | 16.67%25.42M | 7.33%13.64M |
| Administration expense | -8.01%94.66M | -12.80%60M | -10.10%29.33M | 8.85%160.32M | -8.28%102.91M | -9.09%68.81M | -11.09%32.62M | 12.68%147.28M | 26.91%112.2M | 45.74%75.69M |
| Financial expense | 44.63%22.69M | 71.98%12.5M | -38.09%6.73M | 12,304.42%25.88M | 259.68%15.69M | 210.08%7.27M | 187.22%10.87M | -101.60%-212.09K | -373.87%-9.83M | -368.43%-6.6M |
| -Interest expense (Financial expense) | -3.00%30.59M | -0.16%20.74M | 5.69%10.81M | 2.27%42.03M | 4.92%31.54M | 12.29%20.77M | 64.96%10.22M | 64.92%41.1M | 79.91%30.06M | 68.62%18.5M |
| -Interest Income (Financial expense) | 19.52%-5.47M | 11.37%-4.08M | 5.34%-2.34M | 60.10%-9.29M | 64.84%-6.8M | 70.06%-4.6M | -19.45%-2.47M | -42.06%-23.29M | -38.21%-19.35M | -56.03%-15.36M |
| Research and development | -13.58%54.88M | -12.39%34.73M | -18.50%15.87M | 25.83%97.45M | 13.81%63.5M | 11.61%39.64M | 16.11%19.48M | -1.35%77.45M | 6.70%55.8M | 2.04%35.52M |
| Credit Impairment Loss | 79.98%-1.24M | 49.87%-2.08M | 41.28%-443.85K | -24.68%-4.37M | -73.89%-6.2M | -43.52%-4.15M | 83.24%-755.81K | -16.17%-3.51M | -621.56%-3.57M | -8.85%-2.89M |
| Asset Impairment Loss | 58.75%-764.17K | 77.32%-764.17K | ---- | 39.69%-51.76M | -25.54%-1.85M | -78.43%-3.37M | ---- | -9,477.94%-85.83M | -11,648,121.07%-1.48M | ---1.89M |
| Other net revenue | 570.30%37.83M | 456.17%31.38M | 4,839.37%11.65M | 58.76%-64.79M | -222.80%-8.04M | -354.49%-8.81M | 75.54%-245.88K | -46.22%-157.09M | -64.63%6.55M | -74.13%3.46M |
| Fair value change income | ---- | --0 | ---- | 100.83%659.37K | 91.15%-92.58K | -131.46%-1.93M | -58.89%-1.2M | 4.82%-79.25M | -162.34%-1.05M | -162.35%-832.39K |
| Invest income | 75.16%-1.08M | 62.69%-1.13M | -83.38%110.65K | -338.96%-16.16M | -806.75%-4.35M | -1,390.71%-3.02M | -19.66%665.89K | 92.45%-3.68M | 91.61%-480.21K | 105.38%233.66K |
| -Including: Investment income associates | 20.41%-1.97M | 20.41%-1.97M | ---- | -344.60%-14.23M | -252.93%-2.48M | -252.93%-2.48M | ---- | 93.81%-3.2M | ---701.95K | 80.33%-701.95K |
| Asset deal income | -1,376.38%-104.67K | -1,376.38%-104.67K | ---- | -81.32%76.3K | -125.00%-7.09K | -125.00%-7.09K | -125.00%-7.09K | 795.43%408.35K | 148.30%28.36K | -39.99%28.36K |
| Other revenue | 818.05%41.02M | 868.77%35.45M | 1,043.28%11.99M | -54.16%6.77M | -65.87%4.47M | -58.47%3.66M | -69.18%1.05M | -48.25%14.76M | -43.36%13.09M | -53.63%8.81M |
| Operating profit | 27.00%-62.83M | 68.52%-21.37M | 112.14%4.1M | -71.24%-229.39M | -292.12%-86.07M | -250.96%-67.89M | -218.29%-33.8M | -334.99%-133.95M | -75.20%44.8M | -74.59%44.97M |
| Add:Non operating Income | -50.07%383.57K | -48.89%274.75K | -74.87%77.13K | 64.43%918.63K | 72.61%768.24K | 47.03%537.52K | 405.54%307K | 188.53%558.66K | 164.39%445.09K | 265.80%365.58K |
| Less:Non operating expense | -49.30%723.06K | -22.46%427.48K | 317.08%350.9K | -49.52%4.7M | 0.44%1.43M | -58.64%551.28K | -74.55%84.13K | 337.30%9.31M | 6.06%1.42M | 62.99%1.33M |
| Total profit | 27.16%-63.17M | 68.30%-21.52M | 111.40%3.83M | -63.39%-233.17M | -297.90%-86.73M | -254.31%-67.9M | -218.63%-33.58M | -359.15%-142.71M | -75.58%43.82M | -75.04%44M |
| Less:Income tax cost | -2.37%6.04M | 14,999.86%5.5M | 40,276.92%4.57M | -146.19%-9.91M | -61.90%6.18M | -99.68%36.43K | -99.77%11.31K | 38.23%21.47M | -28.36%16.23M | -52.95%11.52M |
| Net profit | 25.51%-69.21M | 60.22%-27.02M | 97.80%-739.91K | -35.99%-223.26M | -436.73%-92.91M | -309.14%-67.94M | -244.28%-33.59M | -515.23%-164.17M | -82.40%27.59M | -78.60%32.49M |
| Net profit from continuing operation | ---- | 60.22%-27.02M | 97.80%-739.91K | -35.99%-223.26M | ---- | -309.14%-67.94M | -244.28%-33.59M | -515.23%-164.17M | -82.40%27.59M | -78.60%32.49M |
| Less:Minority Profit | 36.72%-7.13M | 44.77%-4.56M | 35.88%-2.21M | 1.09%-22.46M | 38.44%-11.27M | 35.58%-8.26M | 26.23%-3.44M | -144.31%-22.7M | -327.88%-18.31M | -2,133.81%-12.83M |
| Net profit of parent company owners | 23.96%-62.07M | 62.36%-22.46M | 104.87%1.47M | -41.94%-200.8M | -277.85%-81.64M | -231.69%-59.67M | -207.86%-30.15M | -389.72%-141.47M | -71.50%45.9M | -70.26%45.31M |
| Earning per share | ||||||||||
| Basic earning per share | 20.00%-0.12 | 63.64%-0.04 | 105.36%0.003 | -42.31%-0.37 | -287.50%-0.15 | -237.50%-0.11 | -212.00%-0.056 | -388.89%-0.26 | -73.33%0.08 | -71.43%0.08 |
| Diluted earning per share | 20.00%-0.12 | 63.64%-0.04 | 105.36%0.003 | -42.31%-0.37 | -287.50%-0.15 | -237.50%-0.11 | -212.00%-0.056 | -388.89%-0.26 | -73.33%0.08 | -71.43%0.08 |
| Other composite income | -124.40%-2.63M | 1,240.31%10.79M | ||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -124.40%-2.63M | ---- | ---- | ---- | 1,240.31%10.79M | ---- | ---- |
| Total composite income | 25.51%-69.21M | 60.22%-27.02M | 97.80%-739.91K | -47.27%-225.89M | -436.73%-92.91M | -309.14%-67.94M | -244.28%-33.59M | -497.46%-153.39M | -82.40%27.59M | -78.60%32.49M |
| Total composite income of parent company owners | 23.96%-62.07M | 62.36%-22.46M | 104.87%1.47M | -55.67%-203.43M | -277.85%-81.64M | -231.69%-59.67M | -207.86%-30.15M | -372.91%-130.68M | -71.50%45.9M | -70.26%45.31M |
| Total composite income of minority owners | 36.72%-7.13M | 44.77%-4.56M | 35.88%-2.21M | 1.09%-22.46M | 38.44%-11.27M | 35.58%-8.26M | 26.23%-3.44M | -144.31%-22.7M | -327.88%-18.31M | -2,133.81%-12.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data